Skip to content
Login Register

#genetic modification

20 public questions tagged with this topic.

Transgenic Plant -2

First GM crop approved for human consumption was:

Flavr Savr tomato developed by Calgene Inc., Davis, California, holds historical status as first genetically modified whole food approved for commercial sale and human consumption. FDA completed voluntary consultation DST 1994 after molecular characterization, Southern blot showing two contiguous T-DNA inserts, compositional analysis comparing sugars, acids, lycopene, vitamin C, glycoalkaloids to non-transgenic parent, toxicity assessment of NPTII at acute dosing in mice, and allergenicity search revealing no homology to known allergens. USDA APHIS determined nonregulated status under 7CFR 340. The antisense PG technology suppressed fruit pectinase reducing softening, allowing vine ripening improving flavor yet extending shelf life, addressing post-harvest losses estimated 20-30%. Despite approval, commercial cultivation failed due to yield drag, high licensing costs, anti-GMO activism, labeling debates and distribution logistics, withdrawn by 1997. Nevertheless regulatory precedent established principle of substantial equivalence, case-by-case safety assessment, voluntary labeling framework later applied to Roundup Ready soybean, Bt cotton, Golden Rice and other transgenic crops, marking transition from laboratory genetics to food biotechnology era and shaping public perception.

Ref: Redenbaugh et al. Safety assessment Flavr Savr FDA 1992; Bruening & Lyons 2000 Food Chem Toxicol.

View Details
Transgenic Plant -1

Chloroplast transformation reduces gene escape because:

Containment of transgenes via organelle transformation addresses environmental concerns about pollen mediated gene flow. In angiosperms like tobacco and Arabidopsis, plastid division during microsporogenesis excludes plastids from generative cell that forms two sperm cells, so mature pollen contains virtually no chloroplast genome. Consequently paternal transmission of plastid DNA extremely rare, estimated at less than 0.1 percent, while maternal transmission through ovule provides nearly 100 percent inheritance. When transgene integrated into plastome via homologous recombination at trnI-trnA locus, progeny from female transplastomic cross inherit tolerance, reciprocal cross does not. This natural exclusion mechanism prevents spread of herbicide or insect resistance traits to related weeds via pollen drift, complementing physical isolation distances. Therefore chloroplast transformation provides biological confinement because chloroplasts absent from most pollen grains, reducing gene escape risk significantly compared to nuclear transgenes transmitted through both pollen and ovule. Comparative analysis of 1000 pollen grains by fluorescence microscopy with GFP-labeled plastids confirms exclusion mechanism. Maternal inheritance ensures transgene stability across generations while preventing environmental escape. This property exploited to express high-value proteins like antibodies and vaccines in chloroplasts with reduced biosafety concerns.

Ref: Heifetz Transgenic Res 2000 plastid absent pollen; Daniell Trends Genet 2002 containment; Maliga Annu Rev Plant Biol 2004 maternal; NCBI NBK153361.

View Details
Transgenic Plant -1

Worldwide maximum cultivated transgenic crop is:

International Service for Acquisition of Agri-biotech Applications annually reports global adoption of GM crops. Historical data from 1996 to 2023 demonstrates herbicide tolerance trait dominates both by trait type and crop species. Among crops, soybean engineered for glyphosate tolerance occupied largest area, reaching over 94 million hectares in 2019, accounting for about half of all GM hectarage. Drivers include high demand for protein meal for animal feed, suitability of herbicide tolerance for large-scale mechanized farming in United States, Brazil, Argentina, adoption of no-till practices conserving soil moisture. Bt cotton occupies second but substantially less area. Edible vaccines and Golden rice remain uncommercialized or limited. Economic analysis shows herbicide tolerant soybean reduced production costs and simplified weed management compared to conventional. Therefore statistical surveys consistently identify herbicide resistant soybean as most widely cultivated transgenic crop worldwide, illustrating market preference for input trait providing management convenience over output traits requiring consumer acceptance. Adoption data illustrates correlation between herbicide tolerance trait and conservation tillage practices reducing soil erosion and carbon emissions. Continued dominance of soybean indicates farmer preference for simplified weed management enabling timely planting over high-value specialty traits requiring niche markets and identity preservation systems.

Ref: ISAAA Brief 55 2019 global status herbicide tolerant soybean dominant; James ISAAA 2014; NCBI NBK131103 statistics; https://www.isaaa.org/resources/publications/briefs/55/

View Details
Gene Therapy

Germline gene therapy is controversial because:

Germline gene therapy introduces intentional genomic alteration into zygotes, totipotent embryonic stem cells, or gamete precursors contributing to both somatic tissues and gonadal germline, establishing heritable change transmitted through fertilization. Using CRISPR Cas9 ribonucleoprotein comprising guide RNA complementary to 20 bp target adjacent to PAM and Cas9 nuclease with HNH and RuvC domains, double-strand break created in totipotent cell repaired by homology-directed repair incorporating donor template correcting mutation throughout embryo. Every tissue including testes and ovaries carries edited allele, so children inherit modification. Controversy stems from inability to obtain consent from future generations, risk of off-target cleavage at homologous loci generating de novo mutations propagated indefinitely, potential mosaicism causing unpredictable phenotype, and concerns regarding eugenic enhancement, loss of diversity, and irreversible alteration of human gene pool. International documents Oviedo Convention, UNESCO Declaration, and FDA regulations prohibit clinical application, distinguishing ethical weight from somatic therapy limited to one person. This mechanistic insight guides vector optimization, dosing strategies, and clinical safety monitoring essential for translational development and regulatory evaluation.

Ref: Nature Rev Genet Germline Editing Ethics 2017; NIH StatPearls Germline Therapy; UNESCO Bioethics Declaration https://www.nature.com/articles/nrg.2017.52.

View Details